Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 125 publications
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 23, 2020
Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 31, 2020
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine.
Journal: Journal of hematology & oncology
Published: August 28, 2019
A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors.
Journal: Investigational new drugs
Published: February 21, 2019
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018).
Journal: Journal for immunotherapy of cancer
Published: February 15, 2019
Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study.
Journal: JCO precision oncology
Published: November 02, 2018
A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors.
Journal: Investigational new drugs
Published: February 15, 2018
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT): An MD Anderson Precision Medicine Study.
Journal: JCO precision oncology
Published: October 31, 2017
Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer.
Journal: Investigational new drugs
Published: August 21, 2017
Phase I Dose-Escalation Study of Anti-CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced Cancers.
Journal: Molecular cancer therapeutics
Published: July 13, 2017
A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 02, 2017
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.
Journal: Scientific reports
Published: February 03, 2017
Last Updated: 09/26/2026